Two Sigma Investments LP Increases Stake in Aspen Aerogels, Inc. (NYSE:ASPN)

Two Sigma Investments LP grew its holdings in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 637.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 592,765 shares of the construction company's stock after purchasing an additional 512,439 shares during the period. Two Sigma Investments LP owned about 0.72% of Aspen Aerogels worth $7,042,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the stock. Sandia Investment Management LP purchased a new stake in shares of Aspen Aerogels during the 4th quarter worth about $89,000. AlphaQuest LLC lifted its stake in shares of Aspen Aerogels by 54.0% in the 4th quarter. AlphaQuest LLC now owns 11,395 shares of the construction company's stock valued at $135,000 after purchasing an additional 3,998 shares during the last quarter. KLP Kapitalforvaltning AS bought a new position in Aspen Aerogels during the fourth quarter valued at about $164,000. Connors Investor Services Inc. acquired a new stake in shares of Aspen Aerogels in the fourth quarter worth about $168,000. Finally, Journey Strategic Wealth LLC bought a new stake in shares of Aspen Aerogels during the 4th quarter worth about $178,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Aspen Aerogels Price Performance

Shares of NYSE ASPN traded down $0.47 during trading on Thursday, reaching $5.96. The company had a trading volume of 1,955,822 shares, compared to its average volume of 2,040,443. The stock has a market cap of $488.94 million, a PE ratio of 37.22 and a beta of 2.72. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. The business's 50 day moving average price is $5.76 and its 200-day moving average price is $9.51. Aspen Aerogels, Inc. has a 52 week low of $4.16 and a 52 week high of $33.15.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The construction company reported ($0.06) EPS for the quarter, beating analysts' consensus estimates of ($0.07) by $0.01. The business had revenue of $78.72 million during the quarter, compared to the consensus estimate of $82.75 million. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. The firm's revenue was down 16.7% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.02) earnings per share. Analysts expect that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have recently commented on ASPN. B. Riley dropped their price objective on Aspen Aerogels from $35.00 to $22.00 and set a "buy" rating on the stock in a research note on Wednesday, February 19th. Wall Street Zen upgraded Aspen Aerogels to a "sell" rating in a research note on Wednesday, February 19th. TD Cowen upgraded Aspen Aerogels to a "strong-buy" rating in a research report on Tuesday, March 11th. Roth Mkm lowered their price objective on Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating on the stock in a research report on Friday, February 14th. Finally, Craig Hallum cut their target price on Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating for the company in a research note on Friday, February 14th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, Aspen Aerogels has an average rating of "Moderate Buy" and an average price target of $18.44.

Insider Activity at Aspen Aerogels

In other news, CEO Donald R. Young bought 20,000 shares of the business's stock in a transaction that occurred on Monday, May 12th. The shares were bought at an average cost of $5.35 per share, for a total transaction of $107,000.00. Following the acquisition, the chief executive officer now directly owns 550,856 shares in the company, valued at approximately $2,947,079.60. This trade represents a 3.77% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 3.40% of the stock is currently owned by insiders.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.